Kodak has raised concerns about its ability to meet debt obligations due within 12 months, with limited liquidity and no committed financing in place. Shares dropped more than 25% on the news.
Despite the warning, the company says it is confident it can restructure its debt and finalise pension plan obligations by year-end. Kodak is also advancing its shift into pharmaceuticals, with a new manufacturing facility nearing completion to diversify beyond its printing business.
.png)
